VHI VALHI INC /DE/

FY2025 10-K
Filed: Mar 10, 2026
Health Care
Industrial Inorganic ChemicalsSEC EDGAR

VALHI INC /DE/ (VHI) filed its fiscal year 2025 10-K annual report with the SEC on Mar 10, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business model: Manufacturing and selling component products (security and marine components) and real estate development, primarily in the U.S.
  • New strategic emphasis on mitigating tariff impacts by increasing electronic component purchases and implementing pricing adjustments in 2025
+3 more insights

Management Discussion & Analysis

  • Revenue $1.86B in 2025, down 1% YoY from $1.89B in 2024; Chemicals segment net sales decreased $27.7M (1%)
  • Chemicals segment operating loss $24.5M in 2025 vs operating income $138.5M in 2024; gross margin 11% vs 19%
+4 more insights

Financial Summary
XBRL

Revenue

$2.1B

Net Income

-$58M

Gross Margin

14.2%

Operating Margin

3.0%

Net Margin

-2.8%

ROE

-5.6%

Total Assets

$2.6B

EPS (Diluted)

$-2.02

Operating Cash Flow

-$36M

Source: XBRL data from VALHI INC /DE/ FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on VALHI INC /DE/

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available